SCHEMBL4831257

SCHEMBL4831257

CCOCC(=O)N(CC)Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 1.00
TRPM8 Q7Z2W7 1/20 0.65
LMNA P02545 3/20 0.62
TSHR P16473 2/20 0.58
MAPK1 P28482 2/20 0.58
NPC1 O15118 2/20 0.58
ALOX15 P16050 1/20 0.58
HSD17B10 Q99714 1/20 0.58
TSPO P30536 1/20 0.55
KDM4E B2RXH2 2/20 0.54
MAPT P10636 1/20 0.54
HTT P42858 1/20 0.54
MGLL Q99685 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
RAB9A P51151 2/20 0.49
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9123266 0.89 ALDH1A1 (0.80) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL2233053 0.81 ALDH1A1 (0.69) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL3456186 0.81 LMNA (0.68) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL9442800 0.81 ALDH1A1 (0.68) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL1195514 0.80 LMNA (0.78) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL2931129 0.79 ALDH1A1 (0.66) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL4075176 0.79 LMNA (0.75) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL29100479 0.79 ALDH1A1 (0.66) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL2716702 0.79 TRPM8 (1.00) ALDH1A1TRPM8LMNATSHRMAPK1
SCHEMBL4835968 0.79 LMNA (0.69) ALDH1A1TRPM8LMNATSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7338960-B2 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2008-03-04 US disclosed
US-7338960-B2 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2008-03-04 US disclosed
US-7338960-B2 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2008-03-04 US disclosed
EP-1513526-B1 PHENYLALKANOIC ACID AND PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORP (US) 2007-11-07 EP disclosed
US-20060089394-A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators SMITHKLINE BEECHAM CORPORATION 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089394-A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators LIPA, PNLIP, CEL ALDH1A1 903/4885TRPM8 813/4885LMNA 3674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.